- Thousand Oaks, California, United States
- On-site
- Full-time · Director
- $150K–$250K per year
- 5–15 years
Lead the strategy, development, and application of quantitative modeling and simulation capabilities that inform early drug-development decisions through prediction of human pharmacokinetics and pharmacodynamics.
Compensation
The expected annual salary range for this role in the U.S. (excluding Puerto Rico) is posted. Actual salary will vary based on several factors including but not limited to, relevant skills, experience, and qualifications. In addition to the base salary, Amgen offers a Total Rewards Plan, based on eligibility, comprising of health and welfare plans for staff and eligible dependents, financial plans with opportunities to save towards retirement or other goals, work/life balance, and career development opportunities that may include: A comprehensive employee benefits package, including a Retirement and Savings Plan with generous company contributions, group medical, dental and vision coverage, life and disability insurance, and flexible spending accounts; A discretionary annual bonus program, or for field sales representatives, a sales-based incentive plan; Stock-based long-term incentives; Award-winning time-off plans; Flexible work models where possible.
Responsibilities
- Define and execute the strategy, roadmap, investment priorities, governance, and operating model for model-informed drug design
- Lead, develop, and retain a team with expertise in mechanistic and empirical modeling, PBPK, PK/PD, and quantitative systems of pharmacology to inform human-dose prediction
- Establish a consistent modeling framework for investigational new drug–enabling activities
- Lead quantitative assessment of candidate differentiation, projected human exposure, dose and regimen feasibility, therapeutic index, and first-in-human starting-dose recommendations
- Drive development and application of PBPK, allometric scaling, mechanistic PK/PD, QSP, and related approaches appropriate to the asset, therapeutic area, and available evidence